EXPRESSION OF UPA AND ITS RECEPTOR BY BOTH NEOPLASTIC AND STROMAL CELLS DURING XENOGRAFT INVASION

被引:55
作者
ROMER, J [1 ]
PYKE, C [1 ]
LUND, LR [1 ]
ERIKSEN, J [1 ]
KRISTENSEN, P [1 ]
RONNE, E [1 ]
HOYERHANSEN, G [1 ]
DANO, K [1 ]
BRUNNER, N [1 ]
机构
[1] UNIV COPENHAGEN,INST PATHOL ANAT,COPENHAGEN,DENMARK
关键词
D O I
10.1002/ijc.2910570419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent studies have shown that molecules involved in generation and regulation of extracellular proteolytic activity are often expressed by non-malignant stromal cells during human cancer invasion. We have studied the expression of the urokinase-type plasminogen activator and the urokinase-type plasminogen activator cell-surface receptor in xenografts of human MDA-MB-231 mammary carcinoma cells growing invasively in nude mice. Northern analysis showed the presence of both human and mouse urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor mRNA in tumor extracts. By in situ hybridization, mRNA for human urokinase-type plasminogen activator and its receptor was detected in virtually all the cancer cells, while mouse urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor mRNA was expressed by tumor-infiltrating fibroblast-like and macrophagelike cells. In invasive areas the cells expressing the 2 murine mRNAs were either the same or located immediately adjacent to each other. This model system has several advantages for studies of the mechanism by which cancer cells induce or recruit stromal cells to produce molecules involved in proteolysis. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:553 / 560
页数:8
相关论文
共 26 条
[1]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[2]   LACZ TRANSDUCED HUMAN BREAST-CANCER XENOGRAFTS AS AN INVIVO MODEL FOR THE STUDY OF INVASION AND METASTASIS [J].
BRUNNER, N ;
THOMPSON, EW ;
SPANGTHOMSEN, M ;
RYGAARD, J ;
DANO, K ;
ZWIEBEL, JA .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) :1989-1995
[3]   PREVENTION OF METASTASIS BY INHIBITION OF THE UROKINASE RECEPTOR [J].
CROWLEY, CW ;
COHEN, RL ;
LUCAS, BK ;
LIU, GH ;
SHUMAN, MA ;
LEVINSON, AD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5021-5025
[4]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[5]  
DANO K, 1994, IN PRESS PROTEOLYSIS
[6]  
ELLIS V, 1994, IN PRESS FIBINOLYSIS
[7]  
GRONDAHLHANSEN J, 1991, AM J PATHOL, V138, P111
[8]   DISTRIBUTION OF COLLAGENASE AND TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP) IN COLORECTAL TUMORS [J].
HEWITT, RE ;
LEACH, IH ;
POWE, DG ;
CLARK, IM ;
CAWSTON, TE ;
TURNER, DR .
INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (05) :666-672
[9]   2 ALTERNATIVELY SPLICED MOUSE UROKINASE RECEPTOR MESSENGER-RNAS WITH DIFFERENT HISTOLOGICAL LOCALIZATION IN THE GASTROINTESTINAL-TRACT [J].
KRISTENSEN, P ;
ERIKSEN, J ;
BLASI, F ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1991, 115 (06) :1763-1771
[10]   UROKINASE-RECEPTOR BIOSYNTHESIS, MESSENGER-RNA LEVEL AND GENE-TRANSCRIPTION ARE INCREASED BY TRANSFORMING GROWTH FACTOR-BETA-1 IN HUMAN A549 LUNG-CARCINOMA CELLS [J].
LUND, LR ;
ROMER, J ;
RONNE, E ;
ELLIS, V ;
BLASI, F ;
DANO, K .
EMBO JOURNAL, 1991, 10 (11) :3399-3407